V. Bril

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

J. Statland, M. Pasnoor, J. Verschuuren, 2021, The Lancet Neurology.

On magnetic properties of U3As4 in strong fields

R. Levitin, V. L. Yakovenko, M. Zelený, 1980 .

Number of potential reversals (turns) and amplitude of the pattern of electrical activity of the abductor pollicis brevis muscle in patients with neurogenic diseases

A. Fuglsang-Frederiksen, V. Bril, 1984, Acta neurologica Scandinavica.